Structural Determinants of μ-Opioid Receptor Antagonism and Respiratory Liability in Phenylfentanyl Analogues.

Key Points

• The study aims to identify structural determinants that influence mu-opioid receptor antagonism and respiratory liability.
• Tested phenylfentanyl analogues for respiratory depression at specific doses.
• Analyzed structural features of the compounds to correlate with effects on mu-opioid receptors.
• No respiratory depression was observed at the tested dose, indicating a lack of intrinsic respiratory liability.
• The findings clarify how structural elements of the fentanyl-derived compounds affect their antagonistic properties on mu-opioid receptors.